Document is current
Any future updates will be listed below
-
Authors
Gill, Shivneet K https://orcid.org/0000-0002-5519-7301
Sugiman-Marangos, Seiji N
Beilhartz, Greg L
Mei, Elizabeth https://orcid.org/0009-0007-4204-9565
Taipale, Mikko https://orcid.org/0000-0003-3811-1761
Melnyk, Roman A https://orcid.org/0000-0002-7187-2362
-
Funding
Funding for this research was provided by:
Canadian Government | Canadian Institutes of Health Research (452580)
Canadian Government | Natural Sciences and Engineering Research Council of Canada (RGPIN-2023-05371)
- License Information
-
More Information
Article History
Received: 2 May 2024
Revised: 15 July 2024
Accepted: 18 July 2024
First Online: 19 August 2024
Disclosure and competing interests statement
: A patent on ‘therapeutic applications of DT homologs’ was filed by RAM, GLB, SNS-M, and SKG. RAM is a co-founder of Nighthawk Therapeutics.
